Sign In

News Story

Sarah Shafir named vice chair of national cancer control group

A great example of our significant leadership role within the cancer control community.

Sarah Shafir, MPH, managing director national partnerships and innovation in the Office of Cancer Research and Implementation (OCRI),was elected vice chair of the Comprehensive Cancer Control National Partnership (CCCNP) this month.

The Partnership is a group of diverse national organizations working together to build and strengthen comprehensive cancer control efforts across the nation. It is an influential group of leading cancer organizations that aims to change the trajectory of the cancer burden in the U.S.

Sarah’s term as chair runs through 2021, at which time she will assume the role of chair for 2022. Her selection as a CCCNP leader is another example of the American Cancer Society’s significant national leadership role within the cancer control community.

As vice chair, Sarah will lend leadership to the efforts of national partners who work collaboratively to provide support to 66 comprehensive cancer control coalitions across the country. The CCCNP offers technical assistance to coalitions as they develop and sustain implementation of comprehensive cancer control plans at the state, tribe, territory, U.S. Pacific Island Jurisdictions, and local levels.

Over this next year, the CCCNP is focusing on addressing systemic racism and health inequities in cancer. As cancer screening rates have plummeted during the pandemic, the CCCNP is also working with coalitions on strategies they can implement to reignite screening in their areas.

From 2002-2010, Sarah served as the former New England Division’s Connecticut vice president for health initiatives. From 2011 to 2014, she was chief of staff/special assistant to the US Ambassador to Australia. In 2015, she returned to ACS where she works at the national level leading a team that is responsible for strategic national partnerships, including the Centers for Disease Control and Prevention (CDC), National Cancer Institute, and the American College of Surgeons Commission on Cancer.

Sarah is currently principal investigator on two grants: the CDC’s Comprehensive Cancer Control Technical Assistance and Training Cooperative Agreement and the CDC’s Strengthening Hospital Systems Capacity Building for Cancer Prevention and Screening Cooperative Agreement with the Center for State, Tribal, Local and Territorial Support. She’s been engaged in comprehensive cancer control coalition work at both the state and national levels for nearly 20 years, and has served on the leadership group of the CCCNP since 2015.

Learn more about the CCCNP and Sarah’s new leadership role here.

back to top